
Avid Bioservices, Inc.
Avid Bioservices, Inc. (CDMO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CDMO · as of Jun 9, 2026
Key Statistics
Explore Avid Bioservices, Inc. Data
cdmo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 90.0%
The CDMO analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing -35.95% downside from the current price of $12.49.
Competitors & Peers
cdmo competitorsStock Performance
Full HistoryAbout Avid Bioservices, Inc.
Avid Bioservices, Inc. operates as a Contract Development and Manufacturing Organization (CDMO), specializing in the development and CGMP-compliant production of biopharmaceutical drug substances. The…
what is avid bioservices, inc. · cdmo stock overview · avid bioservices, inc. company profile · who is avid bioservices, inc. ceo · cdmo NASDAQ · avid bioservices, inc. headquarters · avid bioservices, inc. business segments
About Stock Overview & Key Data
Avid Bioservices, Inc. (CDMO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 4, 1994. As of the latest trading session, CDMO stock price is $12.49, with a market capitalization of $798.9M. The stock has returned +42.09% over the past 12 months and +1.38% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Avid Bioservices, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2024, Avid Bioservices, Inc. reported revenue of $139.9M and net income of -$140.8M. For detailed data — including Avid Bioservices, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Avid Bioservices, Inc. (CDMO) stock price is $12.49. The stock is traded on NASDAQ under the ticker symbol CDMO. The 52-week range is $5.90 – $12.51.